US SB2010 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on June 27 2019 - 25% progression, died in committee
Action: 2019-06-27 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 27 2019 - 25% progression, died in committee
Action: 2019-06-27 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires the National Institutes of Health (NIH) and other agencies to expand and coordinate their efforts to research cerebral cavernous malformation. (Cerebral cavernous malformation is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, and bleeding in the brain.)The NIH must (1) award grants for medical, clinical, and pharmacological research; (2) award grants to support a network of clinical research centers intended to develop a cure for the condition; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients.The Centers for Disease Control and Prevention must award grants to research entities for collecting and reporting data about cerebral cavernous malformation.The Food and Drug Administration must accelerate the clinical trial process for cerebral cavernous malformation by supporting (1) appropriate laboratory indicators of the condition, (2) the qualification of clinical outcome measures related to quality of life, (3) investigational drug applications, and (4) expedited peer-review pathways.
Title
CCM–CARE Act Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2019
Sponsors
| Sen. Tom Udall [D-NM] | Sen. Martin Heinrich [D-NM] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-06-27 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3573 (Same As) 2019-06-28 - Referred to the Subcommittee on Health.
Subjects
Cardiovascular and respiratory health
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health care quality
Health facilities and institutions
Health information and medical records
Health promotion and preventive care
Medical research
Neurological disorders
Research administration and funding
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health care quality
Health facilities and institutions
Health information and medical records
Health promotion and preventive care
Medical research
Neurological disorders
Research administration and funding
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2010/all-info |
| Text | https://www.congress.gov/116/bills/s2010/BILLS-116s2010is.pdf |
